Cargando…
Review of depot aripiprazole for schizophrenia
Improving outcomes in schizophrenia generally requires an improvement in medication adherence. One of the most effective interventions to improve adherence is the use of depot formulations of antipsychotic medications. A new depot aripiprazole formulation for the treatment of schizophrenia will be a...
Autores principales: | Motiwala, Farha Bilal, Siscoe, Kim Stasia, El-Mallakh, Rif S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833619/ https://www.ncbi.nlm.nih.gov/pubmed/24265550 http://dx.doi.org/10.2147/PPA.S32972 |
Ejemplares similares
-
Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020) -
Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
por: Wang, Sheng-Min, et al.
Publicado: (2014) -
Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts, Rona Jeannie, et al.
Publicado: (2016) -
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023) -
Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)